BAFNAPH logo

Bafna Pharmaceuticals Limited Stock Price

NSEI:BAFNAPH Community·₹3.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BAFNAPH Share Price Performance

₹165.01
84.94 (106.08%)
₹165.01
84.94 (106.08%)
Price ₹165.01

BAFNAPH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with proven track record.

2 Risks
1 Reward

Bafna Pharmaceuticals Limited Key Details

₹1.4b

Revenue

₹960.7m

Cost of Revenue

₹462.7m

Gross Profit

₹375.0m

Other Expenses

₹87.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
3.71
32.51%
6.16%
35.5%
View Full Analysis

About BAFNAPH

Founded
1981
Employees
406
CEO
Bansilal Mahaveer Bafna
WebsiteView website
www.bafnapharma.com

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

Recent BAFNAPH News & Updates

Does Bafna Pharmaceuticals (NSE:BAFNAPH) Have A Healthy Balance Sheet?

Dec 24
Does Bafna Pharmaceuticals (NSE:BAFNAPH) Have A Healthy Balance Sheet?

Recent updates

No updates